|
General Information
|
| Term |
congenital myasthenic syndrome 13 |
ID (Ontology) |
DOID:0110676 (Human Disease) |
| Definition |
A congenital myasthenic syndrome characterized by autosomal recessive inheritance of proximal muscle weakness, decremental response to repeated nerve stimulation in EMG studies, and favorable response to acetylcholinesterase inhibitors that has_material_basis_in compound heterozygous mutation in the DPAGT1 gene on chromosome 11q23. |
| Also Known As |
"CMS13" ; "CMSTA2" ; "congenital myasthenic syndrome 13 with tubular aggregates" (for all, see Synonyms field below) |
| Comment |
|
|
Links to External Ontologies
|
|
DO.org
|
|
Annotations
|
|
Records annotated with this term OR any of its CHILD TERMS
|
|
|
|
Records annotated with this exact term (annotations to child terms are NOT included)
|
|
No relevant records available
|
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
| Full annotation statements | Relevant FlyBase reports |
|---|
| Genes |
|---|
congenital myasthenic syndrome 13 | 1 | for disease ribbon | congenital myasthenic syndrome 13 | 1 | model of | congenital myasthenic syndrome 13 | 1 |
|